Industry News

May 15, 2014
By BioPharm International Editors
Hillary Clinton will deliver a keynote address at the 2014 BIO International Convention in San Diego.
May 09, 2014
By BioPharm International Editors
Scientists at the National Cancer Institute found a new cancer immunotherapy method that could be effective against a wide range of cancers.
Apr 30, 2014
By BioPharm International Editors
TAP Biosystems announced that Gallus BioPharmaceuticals is using its ambr15 micro bioreactor system to optimize process development and clone selection of novel antibody therapeutics and biosimilars.
Apr 30, 2014
By BioPharm International Editors
Allergy Therapeutics announced that its Worthing facility has received its Certificate of GMP Compliance following recent inspection by the MHRA.
Apr 28, 2014
GE Healthcare and Promosome sign a licensing agreement that gives GE Healthcare exclusive rights to a new suite of mammalian cell line development technologies.
Apr 28, 2014
By BioPharm International Editors
Sartorius Stedim Biotech's acquisition of AllPure Technologies will extends its portfolio for single-use bioprocessing.
Apr 24, 2014
Spectrum Pharmaceuticals appoints Joseph Turgeon as president and COO.
Apr 23, 2014
By BioPharm International Editors
Bristol-Myers Squibb and Samsung BioLogics expand their manufacturing agreement to cover biologic medicines.
Apr 22, 2014
By BioPharm International Editors
Lilly1s Cyramza is the first FDA-approved treatment for advanced gastric cancer after prior chemotherapy.
Apr 21, 2014
By BioPharm International Editors
Aastrom Biosciences will acquire Sanofi's CTRM business for $6.5 million.
native1_300x100
lorem ipsum